These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1876626)

  • 41. Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder.
    Kodesh A; Katz S; Lerner AG; Finkel B; Sigal M
    J Psychopharmacol; 2001 Mar; 15(1):58-60. PubMed ID: 11277610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
    Freeman EW; Sondheimer SJ; Rickels K; Albert J
    J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermenstrual affect in women with symptomatic premenstrual change.
    Cumming CE; Fox EE; Cumming DC
    J Psychosom Res; 1995 Apr; 39(3):261-9. PubMed ID: 7636770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study.
    Facchinetti F; Fioroni L; Sances G; Romano G; Nappi G; Genazzani AR
    Gynecol Obstet Invest; 1989; 28(4):205-8. PubMed ID: 2695413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
    Freeman E; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sleep pattern changes in menstrual cycles of women with premenstrual syndrome: a preliminary study.
    Chuong CJ; Kim SR; Taskin O; Karacan I
    Am J Obstet Gynecol; 1997 Sep; 177(3):554-8. PubMed ID: 9322623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
    Landén M; Eriksson O; Sundblad C; Andersch B; Naessén T; Eriksson E
    Psychopharmacology (Berl); 2001 May; 155(3):292-8. PubMed ID: 11432692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol.
    Nyberg S
    Contraception; 2013 Jun; 87(6):773-81. PubMed ID: 23121822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclic psychosis associated with the menstrual cycle.
    Stein D; Hanukoglu A; Blank S; Elizur A
    Br J Psychiatry; 1993 Dec; 163():824-8. PubMed ID: 8306131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verapamil in the treatment of premenstrual syndrome: case report.
    Price WA; Giannini AJ
    J Clin Psychiatry; 1986 Apr; 47(4):213-4. PubMed ID: 3957885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychological and physiological changes in severe premenstrual syndrome.
    Asso D; Magos A
    Biol Psychol; 1992 Jul; 33(2-3):115-32. PubMed ID: 1525290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of clonidine in premenstrual tension syndrome.
    Price WA; Giannini AJ
    J Clin Pharmacol; 1984 Oct; 24(10):463-5. PubMed ID: 6542572
    [No Abstract]   [Full Text] [Related]  

  • 54. Effectiveness of kamishoyosan for premenstrual dysphoric disorder: open-labeled pilot study.
    Yamada K; Kanba S
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):323-5. PubMed ID: 17472603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder.
    Hsiao CC; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):593-9. PubMed ID: 15601382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Premenstrual syndrome: documentation by a linear analog scale compared with two descriptive scales.
    Casper RF; Powell AM
    Am J Obstet Gynecol; 1986 Oct; 155(4):862-7. PubMed ID: 3766642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to flumazenil in women with premenstrual dysphoric disorder.
    Le Mellédo JM; Van Driel M; Coupland NJ; Lott P; Jhangri GS
    Am J Psychiatry; 2000 May; 157(5):821-3. PubMed ID: 10784479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Premenstrual exacerbation of depression: one process or two?
    Yonkers KA; White K
    J Clin Psychiatry; 1992 Aug; 53(8):289-92. PubMed ID: 1500406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome].
    Tamborini A; Taurelle R
    Rev Fr Gynecol Obstet; 1993; 88(7-9):447-57. PubMed ID: 8235261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.